Cooper Companies | COO - Umlaufvermögen

Aktienkurs
69.92
Täglich Wechseln
-1.60 -2.24%
Monatlich
-14.67%
Jährlich
-13.91%
Q1 Prognose
67.81




Umlaufvermögen Veränderung Datum
Abbott USD 26B 1.16B 2025-12
Align Technology USD 2.62B 82.47M 2025-12
AtriCure USD 322.52M 21.41M 2025-12
Avanos Medical USD 355.4M 4M 2025-12
Bausch Health Companies USD 6.16B 92M 2025-12
Baxter International USD 6.87B 61M 2025-12
Bayer EUR 32.91B 30M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
Dentsply International USD 2.02B 49M 2025-12
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Globus Medical USD 2.13B 201.25M 2025-12
Haemonetics USD 943.67M 43.99M 2025-12
Hologic USD 3.84B 175.3M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intuitive Surgical USD 12.4B 927.3M 2025-12
J&J USD 55.62B 1.01B 2025-12
Medtronic USD 24B 773M 2025-09
Merit Medical Systems USD 1.04B 54.62M 2025-12
Novartis USD 28.2B 2.26B 2025-09
ResMed USD 3.82B 193.06M 2025-12
STAAR Surgical USD 311.54M 9.66M 2025-12
Steris USD 2.29B 179.9M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.94B 47.65M 2025-12
Utah Medical Products USD 96.53M 2.16M 2025-09
Zimmer Biomet Holdings USD 5.12B 715M 2025-12